Cyclic nucleotide phosphodiesterases and human arterial smooth muscle cell proliferation

Thromb Haemost. 1999 Aug;82(2):424-34.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • 3',5'-Cyclic-AMP Phosphodiesterases / antagonists & inhibitors
  • 3',5'-Cyclic-AMP Phosphodiesterases / physiology*
  • 3',5'-Cyclic-GMP Phosphodiesterases / antagonists & inhibitors
  • 3',5'-Cyclic-GMP Phosphodiesterases / physiology*
  • Aorta / cytology
  • Aorta / physiology
  • Arteries / cytology
  • Arteries / physiology
  • Cell Cycle / physiology
  • Cell Division / drug effects
  • Cell Division / physiology*
  • Cyclic AMP / physiology*
  • Cyclic GMP / physiology*
  • Cyclic Nucleotide Phosphodiesterases, Type 1
  • Cyclin G
  • Cyclin G1
  • Cyclins
  • Gene Expression
  • Humans
  • Muscle, Smooth, Vascular / cytology*
  • Muscle, Smooth, Vascular / physiology
  • Phosphodiesterase Inhibitors / pharmacology
  • Phosphoric Diester Hydrolases / genetics
  • Phosphoric Diester Hydrolases / physiology*
  • Signal Transduction / physiology

Substances

  • CCNG1 protein, human
  • Cyclin G
  • Cyclin G1
  • Cyclins
  • Phosphodiesterase Inhibitors
  • Cyclic AMP
  • Phosphoric Diester Hydrolases
  • 3',5'-Cyclic-AMP Phosphodiesterases
  • Cyclic Nucleotide Phosphodiesterases, Type 1
  • 3',5'-Cyclic-GMP Phosphodiesterases
  • Cyclic GMP